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IgH chainV region gene (V gene) rearrangement and expression during B cell
ontogeny apparently is an ordered and restricted process . In mice there isadevelop-
mental bias toward rearrangement and expression ofa relatively small subset of Ig
V genes located most proximal to the J locus in the germline DNA (1, 2) . Al-
though the relationship between developmental V gene expression and V gene
location is less well understood in man, the repertoire of expressedV genes during
early B cell ontogeny similarly is restricted, apparently containing only 9-39 genes
at 130 d of gestation (3) .
Recently, we found that aV gene member of this restricted human fetal reper-
toire frequently is expressed in chronic lymphocytic leukemia (CLL).' Previously,
we noted that nearly20% of theCLL patients examined had leukemic cells reactive
with amAb, designated G6 (4) . Generated against an IgM rheumatoid factor (RF),
this mAb recognizes an Ig H chain-associated crossreactive idiotype (CRI) that is
present on many IgM paraproteins with RF activity (5) . We found that G6+ leu
kemic cells from unrelated CLL patients express homologous V genes that share
identity with 51p1 (6), a V.1 gene estimated to encode ti14% of the antibody H
chain V regions in the fetal B cell repertoire (3) . These data indicate that the
autoantibody-associated G6 CRI is a serologic marker for a conserved and develop-
mentally restrictedV1 gene that is expressed at high frequency in CLL and early
B cell ontogeny .
We have detected expression of other autoantibody-associated CRIB in CLL and
related B cell malignancies . Nearly one-fifth of patients with K L chain-expressing
CLL or CD5+ small lymphocytic (SL) nonHodgkin's lymphoma (NHL) have neo-
plastic cells reactive with a murine antiidiotypic mAb, designated 17.109 (7, 8) . Gener-
ated against an IgM RF from a patient with mixed cryoglobulinemia, this mAb
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detects a K L chain-associated CRI present on over one-third of all human IgM
RF paraproteinsandmany otherIgM autoantibodies (9, 10) . Yet, an additional mAb
specific for a distinctRFH chain-associated CRI, named Lcl (11), labeled neoplastic
Ig-expressingB cellsfrom 7 of56(13%) patients withCLL orSLNHL (8) . Another
two patients (4%) in this study were found to have malignant cells reactive with B6,
a third mAb specific for an autoantibody H chain-associated CRI that is distinct
from either the G6 CRI or Lcl CRI (8) .
Like the G6 CRI, these CRIs may be serologic markers for expression of con-
served Ig V genes . 17.109-reactive neoplastic cells from unrelated CLL or SLNHL
patients express homologous V,, genes that share 99% homology with Humkv325
(12, 13), aVKIII gene isolated from placental DNA (14) . Similarly, preliminary data
indicate that Lcl and B6 each react with CRIs encoded by a V gene(s) of theV4
and V3 V region subgroups, respectively. As such, these anti-CRI mAbs appar-
ently detect the protein product(s) of conserved Ig V genes that frequently are ex-
pressed in CLL and related B cell malignancies .
Because the fetal repertoire apparently shares with CLL the high frequency ex-
pression of the VH 1 gene used to encode the G6 CRI, we examined splenic tissue
from a 23-wk-old fetus for lymphocytes reactive with G6 and three other mAbs specific
for autoantibody-associated CRIs that commonly are detected on the Ig produced
in CLL and SL NHL .
Materials and Methods
Tissue Samples.
￿
Splenic tissue was obtained from a spontaneously aborted fetus at 161 d
of gestation . Blocks of splenic tissue, N1 cm3 in volume, were frozen in optimal cutting tem-
perature embedding medium (Miles Laboratories, Inc ., Naperville, IL), using methods de-
scribed previously (15) .
Immunohistochemistry.
￿
4-Am sections were prepared from the tissue blocks of frozen fetal
spleen. Enzyme immunohistochemical staining was performed using an avidin-biotin com-
plex immunoperoxidase technique as described (4, 15) . Comparison staining with isotype
control murine mAbs was performed at concentrations equal to those used with the specific
mAb in each experiment. The percent of stained cells within the primary follicles was deter-
mined using photomicrographs ofstained primary follicles . For each mAb ormAb combina-
tion, aminimum of 100 cells in each ofat least five follicles were examined . Statistical calcula-
tions of the mean, SD, and student's t test ofthe percent values were performed on a MacIntosh
Ilcx computer (Apple ComputerCo., Cupertino, CA) using Statview II software (Brainpower
Inc ., Calabasas, CA) .
Antibodies .
￿
B6, a murine IgGI mAb generated against the H chain of an IgM RF
paraprotein, and G6, a murine IgGI mAb (5), were provided by Drs . Rizgar Mageed and
RoyJefferis (University of Birmington, Birmingham, England) . An IgGl mAb specific for
a VKIIIb framework determinant(s) (16), was obtained from Dr. George Abraham (Univer-
sity of Rochester, Rochester, NY) . mAb 17.109 is as described (9) . Lcl, an IgG1 mAb (11),
was the gift of Dr. J . G. P Sissons (Cambridge University, Cambridge, England) . Hybrid-
omas obtained from the American Type Culture Collection (Bethesda, MD) were OKT3,
an IgG2a anti-CD3, and DA4-4, an IgG1 antihuman kH chain . SC-1, an IgG2amAb reac-
tive with human CD5, was provided by Dr. Robert Fox (Scripps Clinic and Research Foun-
dation) . Anti-human K or A L chain-producing hybridomas were as described (17). Anti-
bodies were purified from ascites viaammonium sulfate precipitation and protein A-Sepharose
column chromatography (Bio-Rad Laboratories, Richmond, CA) .
Results
Primary B cell follicles can be identified in the human fetal spleen at 23 wk of
gestation . These follicles generally appear as nodular collections of small lympho-KIPPS ET AL .
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cytes that uniformly bind mAbs specific for human IgM (data not shown). Such
follicles typically are contiguous to perivascular clusters ofT lymphocytes that bind
mAbs to CD3 (Fig . 1, left) or CD5 (Fig . 1, right). The anti-CD5 mAb labels a larger
proportion of lymphocytes than the anti-CD3 mAb, including lymphocytes within
the primary follicles (Fig. 1, arrows) .
We examined photomicrographs ofindividual folliclesfrom the stained fetal spleen
to determinethe proportionsof follicular lymphocytes that are labeled with apartic-
ularmAb or mAbcombination . By dividing the number of stained cells by thenumber
ofcellswithin the follicle, we find that 57% (f 3% SD)of the cellswithin each follicle
express ttLchains (Fig. 2, C), and 41% (t2%)ofthelymphocytesexpress XLchains .
Simultaneous staining with both anti-u and anti-X mAbs labeled virtually all the
cells within each B cell follicle (data not shown) .
High proportions of the lymphocytes within each primary follicle were stained
with any one of the anti-CRI mAbs (Table I) . For any one mAb, there exists little
variation between different follicles in the percent number of cells stained . Thus,
mAbs specific forantibodyH chain-associated CRIB, G6, B6, and Lcl, each stained
6.9% (±1.7% SD), 5.5% (±I .0% SD), and 17% (±0.6% SD), respectively, of the
cells within eachB cell follicle identified . mAb 17.109, specific fora«Lchain-associated
CRI, stained 6.8% (t0.8%) of the follicular lymphocytes .
Simultaneous incubation of the splenic tissue with two or more mAbs allowed
us to distinguish overlapping subsets from noncongruous subsets of mAb-reactive
lymphocytes . A mAb specific for VKIIIb framework determinants, for example,
stained 9.4% (t1%) of the cells within each follicle (Table I) . That 17 .109-reactive
cells comprised a large subset of such VKIII+ lymphocytes was demonstrated in
tissue sections that were stained with both antibodies . The percent of the cells reac-
tive to both 17 .109 and the antiVKIIIb mAbs, 9.3% (±0.5), was comparable with
the proportion of cells labeled by the antiVKI11bmAb alone . However, cells reac-
tive with G6, B6, or Lcl apparently belong to discrete cell subsets, in that simul-
taneous staining with any combination of two such anti-CRI mAbs yielded a per-
FIGURE 1 .
￿
Primary lymphocyte follicles in 23-wk-old human fetal spleen (x20) . Contiguous
tissue sections were labeled with IgG2a mAbs specific for CD3 (kft) orCD5 (right) . Depicted
are the same lymphoid aggregates that were identified in the two sections . The primary 13 cell
follicle (arrow) lies to the left of a perivascular nodule ofT lymphocytes .192
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FIGURE 2 .
￿
Primary B lymphocyte follicles in 23-wk-old human fetal spleen labeled with various
mAbs (x40) . (A) Nonspecific mouse IgG1 (MOPC21) ; (B) anti-human Ic L chain; (C) 17.109 ;
(D) antiVKIIIb ; (E) G6 ; (F) 136 ; (G) Lcl ; (H) pool of 17.109, G6, B6, and Lcl .
TABLE I
Proportions of Lymphocytes within the Primary Follicles of Fetal Spleen
that Are Labeled with Anti-CRI mAbs
Percent of lymphocytes within the primary follicles of fetal spleen that are labeled with anti-
CRI mAbs (mean ± SD) . Columns and rows are labeled with themAb used to stain the tissue
sections . Identity between column and row labels indicates that only one mAb was used .
cent labeling of follicular cells that was comparable with the sum of the proportions
of cells labeled by each mAb separately (Table I) . Costaining tissue sections with
17.109 and either B6 orG6 mAbs labeled a smaller percentage of cells than the sum
of the percentages of cells labeled by each respective mAb alone (p = 0.01 orp =
0.09, respectively). These data are consistent with there being a small percentage
of cells within the primary follicle that can bind both 17 .109 and B6 or 17.109 and
G6 . Simultaneous staining of the fetal spleen with 17 .109, G6, B6, and Lcl labeled
32.3% (±1%) of all lymphocytes within each B cell follicle.
mAbs 17 .109 aVkIIIb
mAbs
G6 B6 Lcl
17 .109 6 .8 t 0.6 9 .3 t 0.6 10 .7 ± 2 .2 10 .7 ± 1 .2 25 .5 ± 2.3
VkIIIb - 9 .4 t 1 .0 ND ND ND
G6 - - 6 .9 t 1 .7 11 .6 t 1 .3 25.8 ± 2 .3
B6 - - - 5.5 ± 1 .0 ND
Lcl - - - - 17.0±2 .2KIPPS ET AL .
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Discussion
This studyindicates that theantibodies produced during earlyB cell development
arecomparable with thoseexpressed inCLL. This wasinferred from arecent study
demonstrating that G6, a major crossreactive idiotype in CLL (4), is encoded by
a V1 gene that was isolated repeatedly from independent clones ofa 130-d fetal
livercDNA library (3, 6) . However, this study directly demonstrates that the protein
product of this V.1 gene actually is expressed frequently by disparate cells within
human fetal lymphoid tissue . In addition, this study extends on previous work by
demonstrating that other CRIs that frequently are expressed in CLL are present
on primary follicular B cells . In particular, the KL ch
expressed by ti7% of all cells, and presumably by 12
within theprimary B cell follicles. Leukemic cells beari
have been found to expressHumkv325, aconservedVK
at single copy in the human haploid genome (12, 13) .
thatVK gene expression by fetal splenocytes is not ran
be expressed by >10% of all K L chain-bearing cells within the human fetal spleen.
Of note, this is a frequency similar to that noted amongleukemic populations from
unrelated persons with CLL (7) .
That the antibodies produced during early B cell development are comparable
with those expressed in CLL or SL NHL may reflect the cell of origin for these
B cell malignancies (reviewed in reference 18). Both neoplasms commonly coexpress
Bcell surface antigens andthe 67-kD pan-T lymphocyte surface antigenCD5 (Leu-
1) . As such, both may be considered neoplasms of the CD5 B cell . Although only
a minor lymphocyte subpopulation in the lymphoid organs and peripheral blood
ofnormal adults (18-22), CD5B cells constitute the predominant B cell subpopula-
tion in human fetal liver and spleen, presumably when the repertoire of expressed
V genes still is restricted (23, 24).
This study also indicates that many of the lymphocytes in early human B cell on-
togeny express surface Igs that are structurally related to IgM autoantibodies . Al-
though it was originally hypothesized that the restricted expression ofhumanV genes
may serve to exclude the appearance ofautoantibodies before the emergence ofeffective
Tcell immunity (3), studies in the mouse have indicated thatmany ofthe antibodies
produced in early B cell ontogeny have anti-self reactivity (25) . That theantibodies
produced by fetal splenic B cells also may have anti-self reactivity is indicated by
ourfinding that the proportion of cells that reactwith both the 17 .109 and G6 mAbs
is less than the sum of the proportions of cells that label with each antibody alone.
This implies thatafraction of the fetal splenocytesmay coexpress bothCRIB . Human
IgM paraproteins that coexpress both CRIB invariably havebeen noted to have RF
activity (26) . Also, the physiologic counterpart to CLL, theCD5B cell, apparently
constitutesa separate B cell lineage that can produceIgM autoantibodies spontane-
ously in vitro (19, 20, 27-29) . Moreover, a high proportion ofCLL patients have
leukemic cells that express sIg with RF activity (17, 30, 31). Expression of such au-
toantibodies may be important developmentally, as thismayserveto stimulate con-
stitutively earlyB lymphocytes that have undergone successful IgV gene rearrange-
ment in the sterile fetal environment .
This study also provides new insight into the physiology of the primary follicle
ofthe human fetal spleen . This is the first study toexamineindividual Bcell follicles
in-associated 17.109 CRI is
of KL chain-bearing cells,
gthe 17.109 CRI invariably
ne that apparently is present
Thus, our findings indicate
om, in that Humkv325 may194
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for the proportions of cells that express idiotypec determinants that reflect expres-
sion of certain highly conserved Ig Vregion genes. Previous studies demonstrating
restriction in the fetal B cell repertoire (3) could not provide any information on
whetherindividual B cell follicles expressall or only part ofthis restricted repertoire.
Conceivably, each B cell follicle couldoriginatefrom afew, if not one, common clonal
ancestors in which successful Ig V gene rearrangement had occurred. However,
our analyses reveal that each examined follicle had cells that expressed disparate
H chain-associated CRIB that presumably are encoded by distinct Ig V genes.
Moreover, there is little variation between primary follicles in the proportions of
cellsthat expressaparticular CRI. Finally, costaining with two or more mAbs specific
for such CRIB labeled a proportion of cells comparable with the sum of the percen-
tages of cells labeled by each mAb alone. These data indicate that the repertoire
of Ig V gene rearrangements within any given follicle is heterogeneous. Further-
more, as there exists little fluctuation between follicles in the relative proportions
of cells that express any one CRI, the repertoire of Ig V genes expressed in any
given follicle may be representative of the entire splenic fetal B cell repertoire. As
such, the programmed development of the Ig V gene repertoire apparently is regu-
lated at the level of the individual primary B cell follicle.
Summary
At 23 wk of gestation, the fetal spleen contains follicles oflymphocytes that coex-
press B cell differentiation antigens, surface Ig, and the 67-kD pan-T lymphocyte
antigen, CD5 (Leu-1). Such cells are thought to represent the normal equivalent
cells of B chronic lymphocytec leukemia (CLL). This B cell leukemia is distinctive
in that high proportions of patients have leukemic cells that express sIgbearingone
or more crossreactive idiotypes (CRIB) that commonly are found on IgM autoanti-
bodies. We performed immunohistochemical studieson fetal spleen at 23 wk of gesta-
tion using a panel ofmAbs specific for autoantibody-associated CRIB. We find that
high proportions (5-17%) of thelymphocytes within each follicle react with any one
of the anti-CRI mAbs. Furthermore, there is little variation between primary fol-
licles in the proportions of cells that express a particular CRI. Using a cocktail of
four anti-CRI mAbs, we detect autoantibody-associated CRIs on approximately one-
third of thelymphocytes within each of the primary B cell follicles. These data indi-
cate that the many ofthe Igs produced during early Bcell development maybe struc-
turally related to IgM autoantibodies and to Ig expressed in CLL and related CD5
B cell malignancies. Furthermore, these studies suggest that the repertoire of Ig V
genes expressed in each primary B cell follicle may be representative of the total
restricted Ig V gene repertoire expressed during early B cell ontogeny.
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human fetal spleen express a crossreactive idiotope(s) in common with cold-reactive autoan-
tibodies with anti-I or anti-i binding activity.
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